# Recombinant Zoster Vaccine in Young Adult Solid Organ Transplant Recipients

> **NCT06162494** · PHASE4 · ENROLLING_BY_INVITATION · sponsor: **Ann & Robert H Lurie Children's Hospital of Chicago** · enrollment: 80 (estimated)

## Conditions studied

- Varicella Zoster

## Interventions

- **BIOLOGICAL:** Recombinant Zoster Vaccine

## Key facts

- **NCT ID:** NCT06162494
- **Lead sponsor:** Ann & Robert H Lurie Children's Hospital of Chicago
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2024-03-18
- **Primary completion:** 2027-03-31
- **Final completion:** 2028-09-30
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2026-03-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06162494

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06162494, "Recombinant Zoster Vaccine in Young Adult Solid Organ Transplant Recipients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06162494. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*